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Imaging Findings of Castleman’s 
Disease Localized in the Axilla: 
A Case Report
Castleman’s disease is a rare benign lymphoproliferative disorder of uncertain
origin which most commonly involves the mediastinum but rarely affects the axil-
la. We report a case of localized Castleman’s disease involving the axillary lymph
node. Mammography revealed a well-defined, homogeneously dense ovoid
mass, 3 cm in size, in the left axilla, while gray-scale ultrasonography (US)
demonstrated a well-defined, uniformly hypoechoic ovoid mass with good
through transmission. Peripheral hypervascularity was observed at power
Dopper US, and early rapid homogeneous enhancement at contrast-enhanced
dynamic CT.
astleman’s disease was first described as a pathologic entity in 1954 and
later defined by Castleman et al. (1) in 1956. A rare lymphoproliferative
disorder of unknown etiology and pathogenesis, it most commonly occurs
in the mediastinum but also in other areas of the body where lymph nodes are normal-
ly found. An axillary location has been reported in only 2% of localized cases (2). We
report a case of localized axillary Castleman’s disease, describing the imaging features
at gray-scale US, power Doppler US, and contrast-enhanced dynamic computed to-
mography (CT).
CASE REPORT
An axillary mass was detected incidentally in a healthy 45-year-old woman who
eight months earlier had undergone transabdominal hysterectomy and bilateral salpin-
go-oophorectomy due to uterine myoma. After surgery she had taken oral estrogen,
and breast mammography demonstrated heterogeneous density. Mediolateral oblique
imaging depicted a well-defined ovoid mass, 3 cm in size, in the left axilla (Fig. 1A).
Gray-scale US using a broad band linear probe (5 12 MHz) revealed a well-defined,
uniformly hypoechoic, ovoid axillary mass, 3 2 3 cm in size and with good through
transmission (Fig. 1B). Power Doppler US of the mass showed prominent linear and
branching peripheral blood flow (Fig. 1C). Precontrast, early phase, and delayed phase
spiral CT scanning was performed prior to, 35 seconds after, and 180 seconds after, re-
spectively, initiation of the intravenous infusion of 130 ml of nonionic contrast media
at a rate of 2.0 mL/sec. Scanning parameters were 5-mm collimation, 9-mm table feed,
and 7-mm reconstruction. At precontrast scanning, the mass was isodense to chest wall
muscle (Fig. 1D), while postcontrast scans demonstrated rapid homogeneous enhance-
ment and washout (Figs. 1E and 1F). The mean density of the mass was 48 HU at pre-
contrast scanning, 124 HU at the early phase, and 78 HU at the delayed phase. CT de-
picted no lymph node enlargement in the mediastinum or abdomen. For US-guided
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A
Fig. 1. 45-year-old woman with localized Castleman’s disease.
A. Mediolateral oblique mammogram depicts a well-defined, high-density ovoid mass (arrows) in the left axilla.
B, C. Transverse gray-scale US reveals a well-defined, homogeneously hypoechoic ovoid mass with good through transmission (B),
while power Doppler US shows that vascularity is more prominent at the periphery than in the central portion of the lymph node. Both lin-
ear and branching vascularity are seen along the periphery (C).
D-F. At triphasic CT performed after the injection of intravenous contrast material, the lymph node (arrows) appears isodense to chest
wall muscle at precontrast scanning (D), shows homogeneous rapid enhancement at the early phase (E), and is washed out at the de-
layed phase (F). 
G, H. Pathologic examination revealed characteristic tight concentric layering of lymphocytes at the periphery of the lymphoid follicles, with
penetration by small capillaries. The peripheral portion of the node has larger and many more blood vessels (arrows) than the central por-
tion (G) (original magnification,  4; hematoxylin-eosin staining). In the germinal center, multinucleated and pleomorphic follicular dendritic
cells (arrows) are present, indicating follicular dendritic cell dysplasia (H) (original magnification,  200; hematoxylin-eosin staining). 
GH
BC
DE Fbiopsy, a 14-G automated gun was used: microscopic ex-
amination revealed tight concentric layering of lympho-
cytes at the periphery of the lymphoid follicles, with pene-
tration by small capillaries, findings which were pathologi-
cally consistent with those of typical hyaline-vascular type
Castleman’s disease. Surgical excision was performed two
weeks after biopsy, and followed by microscopic examina-
tion. This showed that in the peripheral portion of the
lymph node, the number and size of blood vessels were
greater than in the central portion (Fig. 1G), findings which
correlated with those of power Doppler US. In the germi-
nal center, multinucleated and pleomorphic follicular den-
dritic cells were present (Fig. 1H), indicating follicular den-
dritic cell dysplasia. 
DISCUSSION
Since Castleman et al. (1) described 13 cases with the
characteristic histopathologic features of a localized medi-
astinal lymph node hyperplasia in 1956, many such cases
have been reported under various names: lymphonodal
hamartoma, follicular lymphoreticuloma, angiofollicular
lymph node hyperplasia, angiomatous lymphoid hamar-
toma, and giant lymph node hyperplasia. The condition is
currently classified into two major clinical subgroups: local-
ized and disseminated Castleman’s disease (3), and two
major histological types: hyaline-vascular and plasma-cell
(4). Keller et al. (4) found that 91% of all cases were the
hyaline-vascular type and 9% were the plasma-cell type,
while Weisenburger et al. (5) reported that most cases of
disseminated Castleman’s disease were the plasma-cell
type and in affected patients the prognosis was typically
much worse than in those with localized disease. 
Although inflammatory and immunological processes are
thought to be implicated, the exact etiology of localized
Castleman’s disease is unknown. It is thought to represent
either reactive lymphoid hyperplasia due to chronic anti-
genic stimulation by a virus, or a developmental growth
disturbance (3, 6). In our case, the patient presented no
symptoms and the axillary mass was detected incidentally. 
In Castleman’s disease, gray-scale US reveals a uniform
hypoechoic mass (7), while at Doppler US, one that is hy-
pervascular is depicted (8). When differentiating between
benign and malignant axillary nodes, shape and intranodal
blood flow pattern are important. In a study by Yang et al.
(9), gray-scale US showed that the mean longitudinal-trans-
verse axis ratio ( SD) was significantly lower in malignant
(1.8 0.6) than in benign nodes (2.6 0.8), while Doppler
US demonstrated that both the total number of vessels, and
the number of those that were peripheral, were greater in
malignant than in benign axillary nodes. In our case, the
lymph node showed a low mean longitudinal-transverse ax-
is ratio, 1.5, and pathologic examination indicated that pe-
ripherally, many more and larger blood vessels were pre-
sent, findings which suggested malignancy. Because mam-
mography and US revealed no apparent abnormality, we
believed that metastasis from another organ might have oc-
curred. Lymphoid follicular dendritic cell dysplasia, which
can become malignant, was diagnosed, and the observed
peripheral hypervascularity may be related to this condi-
tion. Reactive lymph nodes tend to involve a diffuse histo-
logical process and are more likely to preserve a normal
vascular pattern, with central hilar vessels (10). On the oth-
er hand, malignant changes caused by infiltrating tumor
cells lead to the distortion and destruction of preexisting
nodal vascular structures. After central malignant infiltra-
tion of the lymph node, US-histopathologic correlation of
the findings of lymphadenopathy demonstrated the pres-
ence of residual subcapsular vessels (10). 
At CT, Castleman’s disease appears as a homogeneous
enhancing mass (7). Our patient underwent triphasic CT
for evaluation of the hemodynamics of the lymph node,
and postcontrast scanning demonstrated early rapid en-
hancement and washout. Because rapid homogeneous en-
hancement of the node occurred, CT did not demonstrate
peripheral hypervascularity.
In conclusion, the imaging findings of Castleman’s dis-
ease localized in the axilla were peripheral hypervasculari-
ty at power Doppler US and early rapid enhancement at
dynamic CT. 
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